Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Creative Medical Technology Holdings (CELZ) EPS (Basic) (2016 - 2024)

Historic EPS (Basic) for Creative Medical Technology Holdings (CELZ) over the last 16 years, with Q3 2024 value amounting to -$0.74.

  • Creative Medical Technology Holdings' EPS (Basic) rose 2718.12% to -$0.74 in Q3 2024 from the same period last year, while for Sep 2024 it was -$0.74, marking a year-over-year increase of 2718.12%. This contributed to the annual value of -$3.76 for FY2023, which is 5952.61% up from last year.
  • Creative Medical Technology Holdings' EPS (Basic) amounted to -$0.74 in Q3 2024, which was up 2718.12% from -$1.1 recorded in Q2 2024.
  • Over the past 5 years, Creative Medical Technology Holdings' EPS (Basic) peaked at $12.22 during Q1 2021, and registered a low of -$67.08 during Q4 2020.
  • Its 5-year average for EPS (Basic) is -$3.82, with a median of -$0.75 in 2021.
  • Over the last 5 years, Creative Medical Technology Holdings' EPS (Basic) had its largest YoY gain of 3654449.59% in 2020, and its largest YoY loss of 1259643.95% in 2020.
  • Over the past 5 years, Creative Medical Technology Holdings' EPS (Basic) (Quarter) stood at -$67.08 in 2020, then surged by 97.78% to -$1.49 in 2021, then crashed by 282.19% to -$5.69 in 2022, then soared by 79.03% to -$1.19 in 2023, then skyrocketed by 37.97% to -$0.74 in 2024.
  • Its last three reported values are -$0.74 in Q3 2024, -$1.1 for Q2 2024, and -$0.73 during Q1 2024.